Share Facebook Twitter LinkedIn Pinterest Email Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead. Source link #Gilead #shows #belief #partners #cancer #treatment #billion #buyout belief billion Buyout cancer Gilead Partners Public News shows treatment World News